Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

Impact Therapeutics

Impact Therapeutics is a China-based company.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 1 Feb, 2023

"update inverses"

Golden AI

edited on 1 Feb, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Investors

‌

C&D Emerging Investment

Edits on 16 Jun, 2022

"Entity importer update"

Golden AI

edited on 16 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Is a

Organization

Edits on 4 Jun, 2022

"update inverses"

Golden AI

edited on 4 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Investors

CCBT Private Equity

Edits on 23 May, 2022

"update inverses"

Golden AI

edited on 23 May, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Investors

Sam Isaly

Edits on 19 May, 2022

"update inverses"

Golden AI

edited on 19 May, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Investors

Exome Asset Management

Edits on 4 May, 2022

"update inverses"

Golden AI

edited on 4 May, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Investors

Dingxin Capital

Edits on 17 Aug, 2021

"Funding autocalculation"

Golden AI

edited on 17 Aug, 2021

Edits made to:

Infobox (+3 properties)

Infobox

Latest funding round date

August 3, 2018

Latest funding type

Series C

Total funding amount (USD)

30,000,000

Golden AI

edited on 17 Aug, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Funding rounds

‌

Impact Therapeutics Series C round, August 2018

"Created via: Entity Importer"

Golden AI

created this topic on 17 Aug, 2021

Edits made to:

Infobox (+3 properties)

‌